286 related articles for article (PubMed ID: 24899177)
1. Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor.
Goujon C; Moncorgé O; Bauby H; Doyle T; Barclay WS; Malim MH
J Virol; 2014 Aug; 88(16):9017-26. PubMed ID: 24899177
[TBL] [Abstract][Full Text] [Related]
2. Oligomerization Requirements for MX2-Mediated Suppression of HIV-1 Infection.
Dicks MD; Goujon C; Pollpeter D; Betancor G; Apolonia L; Bergeron JR; Malim MH
J Virol; 2016 Jan; 90(1):22-32. PubMed ID: 26446602
[TBL] [Abstract][Full Text] [Related]
3. The Antiviral Activity of Equine Mx1 against Thogoto Virus Is Determined by the Molecular Structure of Its Viral Specificity Region.
Wagner V; Sabachvili M; Bendl E; Fuchs J; Kochs G
J Virol; 2023 Feb; 97(2):e0193822. PubMed ID: 36749070
[TBL] [Abstract][Full Text] [Related]
4. Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction.
Dicks MDJ; Betancor G; Jimenez-Guardeño JM; Pessel-Vivares L; Apolonia L; Goujon C; Malim MH
PLoS Pathog; 2018 Nov; 14(11):e1007408. PubMed ID: 30496303
[TBL] [Abstract][Full Text] [Related]
5. An evolutionarily conserved N-terminal leucine is essential for MX1 GTPase antiviral activity against different families of RNA viruses.
McKellar J; Arnaud-Arnould M; Chaloin L; Tauziet M; Arpin-André C; Pourcelot O; Blaise M; Moncorgé O; Goujon C
J Biol Chem; 2023 Jan; 299(1):102747. PubMed ID: 36436557
[TBL] [Abstract][Full Text] [Related]
6. Human/bovine chimeric MxA-like GTPases reveal a contribution of N-terminal domains to the magnitude of anti-influenza A activity.
Garigliany MM; Cornet A; Desmecht D
J Interferon Cytokine Res; 2012 Jul; 32(7):326-31. PubMed ID: 22686832
[TBL] [Abstract][Full Text] [Related]
7. Subcellular Localization of MxB Determines Its Antiviral Potential against Influenza A Virus.
Steiner F; Pavlovic J
J Virol; 2020 Oct; 94(22):. PubMed ID: 32907985
[TBL] [Abstract][Full Text] [Related]
8. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection.
Goujon C; Moncorgé O; Bauby H; Doyle T; Ward CC; Schaller T; Hué S; Barclay WS; Schulz R; Malim MH
Nature; 2013 Oct; 502(7472):559-62. PubMed ID: 24048477
[TBL] [Abstract][Full Text] [Related]
9. Mx proteins: GTPases involved in the interferon-induced antiviral state.
Pavlovic J; Schröder A; Blank A; Pitossi F; Staeheli P
Ciba Found Symp; 1993; 176():233-43; discussion 243-7. PubMed ID: 7507812
[TBL] [Abstract][Full Text] [Related]
10. Functional Comparison of Mx1 from Two Different Mouse Species Reveals the Involvement of Loop L4 in the Antiviral Activity against Influenza A Viruses.
Verhelst J; Spitaels J; Nürnberger C; De Vlieger D; Ysenbaert T; Staeheli P; Fiers W; Saelens X
J Virol; 2015 Nov; 89(21):10879-90. PubMed ID: 26292322
[TBL] [Abstract][Full Text] [Related]
11. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
[TBL] [Abstract][Full Text] [Related]
12. Mx Is Not Responsible for the Antiviral Activity of Interferon-α against Japanese Encephalitis Virus.
Zhou J; Wang SQ; Wei JC; Zhang XM; Gao ZC; Liu K; Ma ZY; Chen PY; Zhou B
Viruses; 2017 Jan; 9(1):. PubMed ID: 28075421
[TBL] [Abstract][Full Text] [Related]
13. Evolution and Antiviral Specificities of Interferon-Induced Mx Proteins of Bats against Ebola, Influenza, and Other RNA Viruses.
Fuchs J; Hölzer M; Schilling M; Patzina C; Schoen A; Hoenen T; Zimmer G; Marz M; Weber F; Müller MA; Kochs G
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490593
[TBL] [Abstract][Full Text] [Related]
14. Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein.
Ji S; Na L; Ren H; Wang Y; Wang X
J Virol; 2018 Sep; 92(18):. PubMed ID: 29743377
[TBL] [Abstract][Full Text] [Related]
15. Interferon-induced Mx proteins form oligomers and contain a putative leucine zipper.
Melén K; Ronni T; Broni B; Krug RM; von Bonsdorff CH; Julkunen I
J Biol Chem; 1992 Dec; 267(36):25898-907. PubMed ID: 1281477
[TBL] [Abstract][Full Text] [Related]
16. Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors.
Bulli L; Apolonia L; Kutzner J; Pollpeter D; Goujon C; Herold N; Schwarz SM; Giernat Y; Keppler OT; Malim MH; Schaller T
J Virol; 2016 Aug; 90(16):7469-7480. PubMed ID: 27279606
[TBL] [Abstract][Full Text] [Related]
17. The GTPase Domain of MX2 Interacts with the HIV-1 Capsid, Enabling Its Short Isoform to Moderate Antiviral Restriction.
Betancor G; Dicks MDJ; Jimenez-Guardeño JM; Ali NH; Apolonia L; Malim MH
Cell Rep; 2019 Nov; 29(7):1923-1933.e3. PubMed ID: 31722207
[TBL] [Abstract][Full Text] [Related]
18. The antiviral potential of interferon-induced cotton rat Mx proteins against orthomyxovirus (influenza), rhabdovirus, and bunyavirus.
Stertz S; Dittmann J; Blanco JC; Pletneva LM; Haller O; Kochs G
J Interferon Cytokine Res; 2007 Oct; 27(10):847-55. PubMed ID: 17970694
[TBL] [Abstract][Full Text] [Related]
19. MX2 Viral Substrate Breadth and Inhibitory Activity Are Regulated by Protein Phosphorylation.
Betancor G; Bangham M; Jeon JK; Shah K; Lynham S; Jimenez-Guardeño JM; Malim MH
mBio; 2022 Aug; 13(4):e0171422. PubMed ID: 35880880
[TBL] [Abstract][Full Text] [Related]
20. Intracellular localization and antiviral property of canine Mx proteins.
Nakamura T; Asano A; Okano S; Ko JH; Kon Y; Watanabe T; Agui T
J Interferon Cytokine Res; 2005 Mar; 25(3):169-73. PubMed ID: 15767791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
